The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Precision Oncology Market Research Report 2024

Global Precision Oncology Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1764680

No of Pages : 91

Ask Your Query

Synopsis
Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.

Global Precision Oncology market is projected to reach US$ 184490 million in 2029, increasing from US$ 95500 million in 2022, with the CAGR of 9.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Precision Oncology market research.

Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Precision Oncology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Acrivon Therapeutics
  • Bio-Serv
  • Exact Sciences Corporation
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America
  • QIAGEN
  • Rain Oncology
  • Relay Therapeutics
  • Strata Oncology, Inc.
  • Thermo Fisher Scientific Inc.
  • Variantyx, Inc.

Segment by Type

  • Diagnostics
  • Therapeutics

Segment by Application

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Healthcare Data Companies

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Precision Oncology report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Oncology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Precision Oncology Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Diagnostic Laboratories
1.3.4 Healthcare Data Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Oncology Market Perspective (2018-2029)
2.2 Precision Oncology Growth Trends by Region
2.2.1 Global Precision Oncology Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Precision Oncology Historic Market Size by Region (2018-2023)
2.2.3 Precision Oncology Forecasted Market Size by Region (2024-2029)
2.3 Precision Oncology Market Dynamics
2.3.1 Precision Oncology Industry Trends
2.3.2 Precision Oncology Market Drivers
2.3.3 Precision Oncology Market Challenges
2.3.4 Precision Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Oncology Players by Revenue
3.1.1 Global Top Precision Oncology Players by Revenue (2018-2023)
3.1.2 Global Precision Oncology Revenue Market Share by Players (2018-2023)
3.2 Global Precision Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Precision Oncology Revenue
3.4 Global Precision Oncology Market Concentration Ratio
3.4.1 Global Precision Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Oncology Revenue in 2022
3.5 Precision Oncology Key Players Head office and Area Served
3.6 Key Players Precision Oncology Product Solution and Service
3.7 Date of Enter into Precision Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Oncology Breakdown Data by Type
4.1 Global Precision Oncology Historic Market Size by Type (2018-2023)
4.2 Global Precision Oncology Forecasted Market Size by Type (2024-2029)
5 Precision Oncology Breakdown Data by Application
5.1 Global Precision Oncology Historic Market Size by Application (2018-2023)
5.2 Global Precision Oncology Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Precision Oncology Market Size (2018-2029)
6.2 North America Precision Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Precision Oncology Market Size by Country (2018-2023)
6.4 North America Precision Oncology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Oncology Market Size (2018-2029)
7.2 Europe Precision Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Precision Oncology Market Size by Country (2018-2023)
7.4 Europe Precision Oncology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Oncology Market Size (2018-2029)
8.2 Asia-Pacific Precision Oncology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Precision Oncology Market Size by Region (2018-2023)
8.4 Asia-Pacific Precision Oncology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Oncology Market Size (2018-2029)
9.2 Latin America Precision Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Precision Oncology Market Size by Country (2018-2023)
9.4 Latin America Precision Oncology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Oncology Market Size (2018-2029)
10.2 Middle East & Africa Precision Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Precision Oncology Market Size by Country (2018-2023)
10.4 Middle East & Africa Precision Oncology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acrivon Therapeutics
11.1.1 Acrivon Therapeutics Company Detail
11.1.2 Acrivon Therapeutics Business Overview
11.1.3 Acrivon Therapeutics Precision Oncology Introduction
11.1.4 Acrivon Therapeutics Revenue in Precision Oncology Business (2018-2023)
11.1.5 Acrivon Therapeutics Recent Development
11.2 Bio-Serv
11.2.1 Bio-Serv Company Detail
11.2.2 Bio-Serv Business Overview
11.2.3 Bio-Serv Precision Oncology Introduction
11.2.4 Bio-Serv Revenue in Precision Oncology Business (2018-2023)
11.2.5 Bio-Serv Recent Development
11.3 Exact Sciences Corporation
11.3.1 Exact Sciences Corporation Company Detail
11.3.2 Exact Sciences Corporation Business Overview
11.3.3 Exact Sciences Corporation Precision Oncology Introduction
11.3.4 Exact Sciences Corporation Revenue in Precision Oncology Business (2018-2023)
11.3.5 Exact Sciences Corporation Recent Development
11.4 Illumina, Inc.
11.4.1 Illumina, Inc. Company Detail
11.4.2 Illumina, Inc. Business Overview
11.4.3 Illumina, Inc. Precision Oncology Introduction
11.4.4 Illumina, Inc. Revenue in Precision Oncology Business (2018-2023)
11.4.5 Illumina, Inc. Recent Development
11.5 Invitae Corporation
11.5.1 Invitae Corporation Company Detail
11.5.2 Invitae Corporation Business Overview
11.5.3 Invitae Corporation Precision Oncology Introduction
11.5.4 Invitae Corporation Revenue in Precision Oncology Business (2018-2023)
11.5.5 Invitae Corporation Recent Development
11.6 Laboratory Corporation of America
11.6.1 Laboratory Corporation of America Company Detail
11.6.2 Laboratory Corporation of America Business Overview
11.6.3 Laboratory Corporation of America Precision Oncology Introduction
11.6.4 Laboratory Corporation of America Revenue in Precision Oncology Business (2018-2023)
11.6.5 Laboratory Corporation of America Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Precision Oncology Introduction
11.7.4 QIAGEN Revenue in Precision Oncology Business (2018-2023)
11.7.5 QIAGEN Recent Development
11.8 Rain Oncology
11.8.1 Rain Oncology Company Detail
11.8.2 Rain Oncology Business Overview
11.8.3 Rain Oncology Precision Oncology Introduction
11.8.4 Rain Oncology Revenue in Precision Oncology Business (2018-2023)
11.8.5 Rain Oncology Recent Development
11.9 Relay Therapeutics
11.9.1 Relay Therapeutics Company Detail
11.9.2 Relay Therapeutics Business Overview
11.9.3 Relay Therapeutics Precision Oncology Introduction
11.9.4 Relay Therapeutics Revenue in Precision Oncology Business (2018-2023)
11.9.5 Relay Therapeutics Recent Development
11.10 Strata Oncology, Inc.
11.10.1 Strata Oncology, Inc. Company Detail
11.10.2 Strata Oncology, Inc. Business Overview
11.10.3 Strata Oncology, Inc. Precision Oncology Introduction
11.10.4 Strata Oncology, Inc. Revenue in Precision Oncology Business (2018-2023)
11.10.5 Strata Oncology, Inc. Recent Development
11.11 Thermo Fisher Scientific Inc.
11.11.1 Thermo Fisher Scientific Inc. Company Detail
11.11.2 Thermo Fisher Scientific Inc. Business Overview
11.11.3 Thermo Fisher Scientific Inc. Precision Oncology Introduction
11.11.4 Thermo Fisher Scientific Inc. Revenue in Precision Oncology Business (2018-2023)
11.11.5 Thermo Fisher Scientific Inc. Recent Development
11.12 Variantyx, Inc.
11.12.1 Variantyx, Inc. Company Detail
11.12.2 Variantyx, Inc. Business Overview
11.12.3 Variantyx, Inc. Precision Oncology Introduction
11.12.4 Variantyx, Inc. Revenue in Precision Oncology Business (2018-2023)
11.12.5 Variantyx, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock